Developing new chemical methods to create unique anti-cancer compounds
Novel Dearomative Indole Annulation Reactions, Beckmann Fragmentations, and Their Applications to Synthesis
This study is all about creating new chemical compounds that could help fight cancer, and it's for anyone interested in how innovative science might lead to better treatments for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth College NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project ID | NIH-10890803 on NIH RePORTER |
What this research studies
This research focuses on creating innovative chemical technologies that involve ring-forming reactions to produce new molecular entities with potential biomedical applications. The project aims to synthesize unique indoline alkaloids, which are compounds known for their important biological properties, including anti-cancer effects. The researchers will work on synthesizing specific molecules that have not been created before, such as strychnochromine and cabucraline, and will explore new chemical reactions to enhance the efficiency of these processes. Patients may benefit from the development of new anti-cancer agents derived from these compounds.
Who could benefit from this research
Good fit: Ideal candidates for this research would be patients with cancer who are seeking new treatment options.
Not a fit: Patients who do not have cancer or are not interested in experimental treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel anti-cancer drugs that are more effective in treating various cancers.
How similar studies have performed: Other research has shown promise in developing new anti-cancer agents through innovative chemical synthesis, indicating that this approach could yield significant results.
Where this research is happening
Hanover, United States
- Dartmouth College — Hanover, United States (Active)
Researchers
- Principal investigator: Wu, Jimmy — Dartmouth College
- Study coordinator: Wu, Jimmy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.